title: Onset of flexural psoriasis during infliximab treatment for Crohn's disease.
authors.forename: L
authors.initials: L
authors.lastname: Peramiquel
authors.forename: L
authors.initials: L
authors.lastname: Puig
authors.forename: J
authors.initials: J
authors.lastname: Dalmau
authors.forename: E
authors.initials: E
authors.lastname: Ricart
authors.forename: E
authors.initials: E
authors.lastname: Roe
authors.forename: A
authors.initials: A
authors.lastname: Alomar
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D011565:Psoriasis / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab